has been cited by the following article(s):
|
[1]
|
Effects of sea buckthorn (Hippophae rhamnoides L.) on factors related to metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trial
|
|
Phytotherapy …,
2022 |
|
|
|
|
[2]
|
Phytochemistry and pharmacology of sea buckthorn (Elaeagnus rhamnoides; syn. Hippophae rhamnoides): progress from 2010 to 2021
|
|
Phytochemistry Reviews,
2022 |
|
|
|
|
[3]
|
Academic Press is an imprint of Elsevier 125 London Wall, London EC2Y 5AS, United Kingdom 525 B Street, Suite 1650, San Diego, CA 92101, United States …
|
|
2018 |
|
|
|
|
[4]
|
Ezetimibe alleviates non-alcoholic fatty liver disease through the miR-16 inhibiting mTOR/p70S6K1 pathway
|
|
RSC Advances,
2017 |
|
|
|
|
[5]
|
Effect of sea buckthorn (Hippophae rhamnoides L.) on blood lipid profiles: a systematic review and meta-analysis from 11 independent randomized controlled trials
|
|
Trends in Food Science & Technology,
2016 |
|
|
|
|
[6]
|
A review of therapeutic and non-therapeutic properties of sea buckthorn
|
|
Advanced Herbal Medicine,
2015 |
|
|
|
|
[7]
|
Is Sea Buckthorn Oil Good for You?
|
|
|
|
|
|
|
[8]
|
THERAPUTICAL USES AND PHARMACOLOGICAL PROFILE OF SEABUCKTHORN: A REVIEW
|
|
|
|
|
|
|
[1]
|
Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro
Journal of Ethnopharmacology,
2024
DOI:10.1016/j.jep.2024.118657
|
|
|
|
|
[2]
|
A Review on the Protecting Effects and Molecular Mechanisms of Berries Against a Silent Public Health Concern: Non-Alcoholic Fatty Liver Disease
Antioxidants,
2024
DOI:10.3390/antiox13111389
|
|
|
|
|
[3]
|
Phytochemistry and pharmacology of sea buckthorn (Elaeagnus rhamnoides; syn. Hippophae rhamnoides): progress from 2010 to 2021
Phytochemistry Reviews,
2023
DOI:10.1007/s11101-022-09832-1
|
|
|
|
|
[4]
|
Effects of sea buckthorn (Hippophae rhamnoides L.) on factors related to metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trial
Phytotherapy Research,
2022
DOI:10.1002/ptr.7596
|
|
|
|
|
[5]
|
Phytochemistry and pharmacology of sea buckthorn (Elaeagnus rhamnoides; syn. Hippophae rhamnoides): progress from 2010 to 2021
Phytochemistry Reviews,
2022
DOI:10.1007/s11101-022-09832-1
|
|
|
|
|
[6]
|
Management of High Altitude Pathophysiology
2018
DOI:10.1016/B978-0-12-813999-8.00003-3
|
|
|
|
|
[7]
|
Effect of sea buckthorn (Hippophae rhamnoides L.) on blood lipid profiles: A systematic review and meta-analysis from 11 independent randomized controlled trials
Trends in Food Science & Technology,
2017
DOI:10.1016/j.tifs.2016.11.007
|
|
|
|
|
[8]
|
Ezetimibe alleviates non-alcoholic fatty liver disease through the miR-16 inhibiting mTOR/p70S6K1 pathway
RSC Adv.,
2017
DOI:10.1039/C7RA03949B
|
|
|
|